Neuroone Medical Technologies (NMTC) Net Cash Flow (2010 - 2026)

Neuroone Medical Technologies (NMTC) has reported Net Cash Flow for 17 consecutive years, with -$756415.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 111.26% year-over-year to -$756415.0; the trailing twelve-month figure through Jun 2026 stood at -$6.0 million (down 193.34% YoY), and the FY2025 full-year result was $5.1 million, up 232.31% from the prior year.
• Net Cash Flow was little changed at -$756415.0 in Q2 2026 per NMTC's latest filing, from -$757605.0 in the prior quarter.
• Across five years, Net Cash Flow topped out at $6.7 million in Q2 2025 and bottomed at -$3.5 million in Q4 2022.
• Historically, Net Cash Flow has averaged -$785373.7 across 5 years, with a median of -$786141.5 in 2024.
• The widest YoY moves for Net Cash Flow: up 924.8% in 2025, down 823.81% in 2025.
• Over 5 years, Net Cash Flow stood at -$3.5 million in 2022, then gained by 24.37% to -$2.6 million in 2023, then soared by 87.67% to -$325692.0 in 2024, then plunged by 823.81% to -$3.0 million in 2025, then soared by 74.86% to -$756415.0 in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$756415.0, -$757605.0, and -$3.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.